UK markets closed

ImmunoGen, Inc. (IMGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.58-0.02 (-0.36%)
At close: 4:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
134,718
132,299
82,271
53,446
115,447
Cost of revenue
121,597
114,592
114,522
174,456
139,739
Gross profit
13,121
17,707
-32,251
-121,010
-24,292
Operating expenses
Research development
121,597
114,592
114,522
174,456
139,739
Selling general and administrative
39,945
38,600
38,489
36,746
33,911
Total operating expenses
161,542
153,192
153,011
211,202
173,650
Operating income or loss
-26,824
-20,893
-70,740
-157,756
-58,203
Interest expense
22,144
23,202
16,974
10,726
16,722
Total other income/expenses net
-367
-277
-16,419
-361
-21,087
Income before tax
-49,335
-44,372
-104,133
-168,843
-96,012
Income from continuing operations
-49,335
-44,372
-104,133
-168,843
-96,012
Net income
-49,335
-44,372
-104,133
-168,843
-96,012
Net income available to common shareholders
-49,335
-44,372
-104,133
-168,843
-96,012
Basic EPS
-
-0.25
-0.70
-1.20
-0.98
Diluted EPS
-
-0.25
-0.70
-1.20
-0.98
Basic average shares
-
176,153
148,311
139,946
98,068
Diluted average shares
-
176,153
148,311
139,946
98,068
EBITDA
-
-19,069
-83,131
-150,706
-73,327